Here's Why Hopeful Marijuana Stock Cara Therapeutics Surged 15% In March

newsfeedback@fool.com (Sean Williams), The Motley Fool
Wed, 04/05/2017 - 9:21am

Shares of Cara Therapeutics (NASDAQ: CARA), a clinical-stage biopharmaceutical company focused on treating pain and pruritus (itching), surged an impressive 15% in March, according to data from S&P Global Market Intelligence. Two factors appear to have played a key role in pushing shares of Cara noticeably higher.Without question, the biggest catalyst last month was the release of positive top-line data from Part A of its phase 2/3 trial for IV CR845 in patients with chronic kidney disease-associated pruritus (known officially as uremic pruritus).

NEXT
Topics:  cara therapeutics nasdaq   cara    march   s&p global market   intelligence   part a   skindex-10   food   drug administration   part b   images   cara    cara   iv cr845   surged   pruritus   met   endpoint   shares   itching   score   worst   data   doses   
BING NEWS:
  • StockNews.com Begins Coverage on Cara Therapeutics (NASDAQ:CARA)
    Research analysts at StockNews.com started coverage on shares of Cara Therapeutics (NASDAQ:CARA – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the ...
    01/7/2025 - 5:14 pm | View Link
  • Brokerages Set Cara Therapeutics, Inc. (NASDAQ:CARA) Target Price at $2.32
    Shares of Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) have been assigned an average rating of “Hold” from the five analysts that are currently covering the stock, Marketbeat Ratings ...
    01/1/2025 - 4:08 pm | View Link
  • Cara Therapeutics Inc (CARA) Stock: More Strategic Than Meets the Eye
    On Monday, Cara Therapeutics Inc (CARA) stock saw a decline, ending the day at $0.35 which represents a decrease of $-0.03 or -7.89% from the prior close of $0.38. The stock opened at $0.37 and ...
    12/31/2024 - 9:29 am | View Link
  • Cara Therapeutics Shares Rise 20% Following Reverse Stock Split
    Cara Therapeutics shares gained after a recent 1-for-20 reverse stock split became effective. The stock was about 20% higher, at $5.11, in midday Tuesday trading. Shares of the biopharmaceutical ...
    12/31/2024 - 6:11 am | View Link
  • Cara Therapeutics announces effective date for 1-for-12 reverse stock split
    Cara Therapeutics, a Stamford-based biopharmaceutical company, said Friday it plans to conduct a 1-for-12 reverse stock split in an effort to regain compliance with the minimum bid price requirement ...
    12/30/2024 - 3:23 am | View Link
  • More

 

NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News